The presentations in the third NIOG meeting with pharmaceutical industry are available. There are lots of interesting topics such as Q&A updates, the risk of N-nitroso-API formation, the progress of call for review, and so on. And NDSRIs have a strong impact on call for review…
8 Likes
Yes, it is very good and informative